Sign in

CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. SC 13G Stake Amended Statement of Ownership
  3. CT ORDER Other Confidential Order
  4. SC 13D Stake Beneficial Ownership Report
  5. SC 13D Stake Beneficial Ownership Report
  6. SC 13D Stake Beneficial Ownership Report
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy 10% owner bought 500,198 shares at $11.00 ($5,502,178)
  9. 4 Open-market buy 10% owner bought 394,918 shares at $11.00 ($4,344,098)
  10. 4 Open-market buy Director bought 11,237 shares at $11.00 ($123,607)
  11. 4 Open-market buy Director bought 394,918 shares at $11.00 ($4,344,098)
  12. 4 Open-market buy 10% owner bought 333,466 shares at $11.00 ($3,668,126)
  13. 8-K Event Bylaws or fiscal year change
  14. 424B4 Offering Prospectus
  15. EFFECT Other Notice of Effectiveness
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 43 of 45 · 895 filings